PVI
GOSS icon

Pura Vida Investments’s Gossamer Bio GOSS Stock Holding History

Pura Vida Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-169,900
Closed -$2.04M – 214
2022
Q3 		$2.04M Buy
169,900
+69,900
+70% +$868K 0.12% 133
2022
Q2 		$837K Buy
+100,000
New +$775K 0.05% 170

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's GOSS Position: Q4 2022 in Review

Pura Vida Investments sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 341,878 shares — an estimated $4.1M sold.

Pura Vida Investments first reported a position in GOSS in Q1 2021 and held it in 7 quarters. The position peaked at $4.1M in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Pura Vida Investments reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 341,878 Gossamer Bio shares in Q4 2022, an estimated $4.1M.
  • Pura Vida Investments first reported a position in Gossamer Bio in Q1 2021 and held it in 7 quarters.
  • Pura Vida Investments's Gossamer Bio position peaked at $4.1M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.